The Aporia
Xin, L. (2026, October 19). US prize-winning cancer scientist Wan Fengyi joins China’s Zhejiang University. South China Morning Post. https://www.scmp.com/news/china/science/article/3370955/us-prize-winning-cancer-scientist-wan-fengyi-joins-chinas-zhejiang-university?utm_source=rss_feed
Xin, Ling. “US prize-winning cancer scientist Wan Fengyi joins China’s Zhejiang University.” South China Morning Post, 19 Oct. 2026, https://www.scmp.com/news/china/science/article/3370955/us-prize-winning-cancer-scientist-wan-fengyi-joins-chinas-zhejiang-university?utm_source=rss_feed.
Xin, Ling. “US prize-winning cancer scientist Wan Fengyi joins China’s Zhejiang University.” South China Morning Post, October 19, 2026. https://www.scmp.com/news/china/science/article/3370955/us-prize-winning-cancer-scientist-wan-fengyi-joins-chinas-zhejiang-university?utm_source=rss_feed.
Dated from the outlet's own feed. Check the original for its byline.
Wan Fengyi, a prize-winning cancer scientist formerly based at the Johns Hopkins Bloomberg School of Public Health, has joined Zhejiang University in Hangzhou, China. Wan's research pioneered groundbreaking links between stomach infections and colon cancer. He now holds a chair professorship at Zhejang University, working at a national laboratory affiliated with its Second Affiliated Hospital, which focuses on developing medical devices for use inside blood vessels. This move is part of a trend: Wan is one of at least five senior scientists from top US institutions to join Zhejiang University this year.